Details of issuance or disposal
Exercise status report for the 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued through a third-party allotment
Shares delivered during the month: 3,540,000 shares (3,540,000 new shares and 0 treasury shares transferred)
The lower thin line represents the existing number of shares to which these shares will be added.
Exercise ratio under the exercise restrictions: 7.8% (3,540,000 shares delivered / 45,593,560 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares delivered during the month: 3,540,000 shares (3,540,000 new shares and 0 treasury shares transferred) |
| Intended allottee | EVO FUND (the allottee at the time of issuance on 13 May 2026) |
| Dilution Rate | Exercise ratio under the exercise restrictions: 7.8% (3,540,000 shares delivered / 45,593,560 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 50,882,560 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | The exercise price during the subject month ranged from ¥27.00 to ¥31.00 per day. Details of the adjustment clause and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 210,000 rights; exercised during the subject month: 35,400 rights; unexercised at the end of the preceding month: 157,110 rights; unexercised at the end of the subject month: 121,710 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 13 May 2026 / Type Issuance of the 22nd Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 22nd Stock Acquisition Rights in July 2026.